Effect of splenectomy on attenuation of LPS-induced AKI through GTS-21-induced cholinergic anti-inflammatory pathway

Yang Gao1, Kai Kang2, Xinyu Zhang2

  • 1Department of Critical Care Medicine, The Second Affiliated Hospital of Harbin Medical University Harbin 150086, China.

Insights

Splenectomy partially offsets GTS-21

Area of Science:

  • Renal Physiology and Pathology
  • Inflammation and Immunology
  • Sepsis Research

Background:

  • Lipopolysaccharide (LPS) triggers acute kidney injury (AKI) via inflammatory pathways.
  • The cholinergic anti-inflammatory pathway, activated by GTS-21, shows potential in mitigating LPS-induced AKI.
  • The role of splenectomy in modulating this pathway and its impact on AKI remains unclear.

Purpose of the Study:

  • To investigate the effect of splenectomy on LPS-induced AKI.
  • To elucidate the role of the GTS-21-activated cholinergic anti-inflammatory pathway in this context.
  • To determine how splenectomy influences the protective effects of GTS-21.

Main Methods:

  • Establishment of LPS-induced renal injury model in C57BL/6 mice.
  • Assessment of splenectomy's impact with and without LPS and GTS-21 treatments.
  • Histopathological (HE, Tunel) and biochemical analyses (creatinine, cystatin-C) of renal tissues.
  • Gene and protein expression analysis (qRT-PCR, Western blot) for inflammatory markers, apoptosis-related proteins, and the α7nAChR pathway.

Main Results:

  • LPS significantly increased renal injury and apoptosis; GTS-21 treatment attenuated these effects.
  • Splenectomy combined with GTS-21 increased apoptosis, partially counteracting GTS-21's protective effect.
  • Splenectomy reduced circulating inflammatory cytokines but also inhibited the GTS-21-mediated activation of the α7nAChR pathway.
  • While GTS-21 attenuated LPS-induced AKI, splenectomy's overall impact was complex, balancing reduced systemic inflammation against impaired pathway activation.

Conclusions:

  • GTS-21 effectively attenuates LPS-induced AKI by activating the cholinergic anti-inflammatory pathway.
  • Splenectomy can suppress the anti-inflammatory and anti-apoptotic effects of GTS-21.
  • Splenectomy has a dual effect on LPS-induced AKI: it reduces circulating inflammatory cytokines but may also hinder beneficial pathway activation.
  • The net impact of splenectomy on LPS-induced AKI is contingent on the balance between these opposing effects.

Related Concept Videos

Transcription Attenuation in Prokaryotes02:42

Transcription Attenuation in Prokaryotes

Transcriptional attenuation occurs when RNA transcription is prematurely terminated due to the formation of a terminator mRNA hairpin structure.  Bacteria use these hairpins to regulate the transcription process and control the synthesis of several amino acids including histidine, lysine, threonine, and phenylalanine. Transcription attenuation takes place in the non-coding regions of mRNA.
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
18.2K
Induced-fit Model01:13

Induced-fit Model

Most chemical reactions in cells require enzymes—biological catalysts that speed up the reaction without being consumed or permanently changed. They reduce the activation energy needed to convert the reactants into products. Enzymes are proteins, that usually work by binding to a substrate—a reactant molecule that they act upon.
Enzymes exhibit substrate specificity, meaning that they can only bind to certain substrates. This is mainly determined by the shape and chemical...
89.0K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
27.3K
Cholinergic Antagonists: Therapeutic Uses01:26

Cholinergic Antagonists: Therapeutic Uses

Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:    
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
1.4K
Cholinergic Neurons: Neurotransmission01:23

Cholinergic Neurons: Neurotransmission

Cholinergic neurotransmission involves the synthesis and the release of acetylcholine (ACh) in order to transmit nerve impulses across the synapse. The process begins with the synthesis of acetyl CoA, a precursor for ACh, from ATP, acetate, and coenzyme A in the mitochondria. Choline, another vital precursor, is transported inside the neuron through choline transporters, including high-affinity choline transporter CHT1, low-affinity choline transporter CTL1, and lower-affinity choline...
5.2K
Cholinergic Receptors: Muscarinic01:25

Cholinergic Receptors: Muscarinic

The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine. 
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
5.0K